Marina Biotech to Participate in Joseph Gunnar''s Pioneers 2017 Conference on May 2
(firmenpresse) - CITY OF INDUSTRY, CA -- (Marketwired) -- 04/27/17 -- Marina Biotech, Inc. (OTCQB: MRNA), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for disease intersections of arthritis, hypertension and cancer, announced today that Joseph Ramelli, Chief Executive Officer, will present at Joseph Gunnar''s Pioneers 2017 Conference to be held at the Mandarin Oriental Hotel in New York City on Tuesday, May 2, 2017 at 2:30 pm ET.
Investors attending the conference who wish to meet with management for a one-on-one meeting should notify their appropriate contact or e-mail .
For more information and registration, please visit the .
Marina Biotech is a biotechnology company focused on the development and commercialization of innovative therapeutics for disease intersections of arthritis, hypertension, and cancer. Our pipeline includes combination therapies of oligonucleotide-based therapeutics and small molecules. The Marina Biotech pipeline currently includes a clinical program in Familial Adenomatous Polyposis (a precancerous syndrome). By its merger with IthenaPharma, Marina Biotech recently acquired IT-102/IT-103 - next generation celecoxib - which will be developed together with CEQ508 as a therapeutic enhancer for therapies against FAP and CRC. IT-102/IT-103 are also being developed for the treatment of combined arthritis/ hypertension and treatment of pain requiring high dose of celecoxib. Additional information about Marina Biotech is available at .
Garth Russell / Allison Soss
KCSA Strategic Communications
Phone: (212) 896-1250 / (212) 896-1267
Email: /
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 27.04.2017 - 12:00 Uhr
Sprache: Deutsch
News-ID 1501036
Anzahl Zeichen: 2543
contact information:
Contact person:
Town:
CITY OF INDUSTRY, CA
Phone:
Kategorie:
Drugs
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 334 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Marina Biotech to Participate in Joseph Gunnar''s Pioneers 2017 Conference on May 2
"
steht unter der journalistisch-redaktionellen Verantwortung von
Marina Biotech, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
